ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Feb 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2016-02-06

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-06	Common Stock	F	13048	$3.46	Disposed	121952	Direct

Footnotes

F1: This transaction reflects the payment of the tax liability by withholding securities incident to the vesting of restricted stock units.